Independent Franchise Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $971M | Buy |
|
|||||
|
2025
Q1 | $1.06B | Buy |
|
|||||
|
2024
Q4 | $969M | Buy |
|
|||||
|
2024
Q3 | $734M | Sell |
|
|||||
|
2024
Q2 | $606M | Buy |
|
|||||
|
2024
Q1 | $762M | Sell |
|
|||||
|
2023
Q4 | $722M | Sell |
|
|||||
|
2023
Q3 | $856M | Buy |
|
|||||
|
2023
Q2 | $802M | Buy |
|
|||||
|
2023
Q1 | $817M | Sell |
|
|||||
|
2022
Q4 | $851M | Sell |
|
|||||
|
2022
Q3 | $856M | Sell |
|
|||||
|
2022
Q2 | $954M | Sell |
|
|||||
|
2022
Q1 | $1.1B | Sell |
|
|||||
|
2021
Q4 | $986M | Buy |
|
|||||
|
2021
Q3 | $746M | Sell |
|
|||||
|
2021
Q2 | $912M | Buy |
|
|||||
|
2021
Q1 | $655M | Buy |
|
|||||
|
2020
Q4 | $604M | Buy |
|
|||||
|
2020
Q3 | $579M | Sell |
|
|||||
|
2020
Q2 | $638M | Buy |
|
|||||
|
2020
Q1 | $496M | Buy |
|
|||||
|
2019
Q4 | $495M | Sell |
|
|||||
|
2019
Q3 | $399M | Buy |
|